TerminatedPHASE2, PHASE3NCT00080119

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Studying Pneumocystosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Principal Investigator: Shabir Madhi, MD, MD
University of Witwatersrand, South Africa
Intervention: Isoniazid (INH)(drug)
Enrollment: 1354 enrolled
Eligibility: All sexes
Timeline: 2004 – 2009

Study locations (6)

Princess Marina Hospital, Gaborone, Botswana
University of Cape Town, Red Cross Children's Hospital, Cape Town, South Africa
University of Stellenbosch, Tygerberg Hospital, Cape Town, South Africa
Nelson R. Mandela School of Medicine, University of KwaZulu Natal, Durban, Durban, South Africa
Perinatal HIV Research Unit at Chris Hani Baragwanath Hospital, Johannesburg, South Africa
Chris Hani Baragwanath Hospital, Harriet Shezi Clinic, Johannesburg, South Africa

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID) · Comprehensive International Program of Research on AIDS · Secure the Future Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00080119 on ClinicalTrials.gov

Other trials for Pneumocystosis

Additional recruiting or active studies for the same condition.

See all trials for Pneumocystosis →

← Back to all trials